Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy

MLA

Lama Abdelnour, et al. “Worsening Proteinuria and Renal Function after Intravitreal Vascular Endothelial Growth Factor Blockade for Diabetic Proliferative Retinopathy.” Clinical Kidney Journal, vol. 13, no. 6, Sept. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b427cb04a056be8d720add89a04c6589&authtype=sso&custid=ns315887.

APA

Lama Abdelnour, Michael Shye, Jean Hou, Collin Mccannel, Ngoc Tram-Tran, Maham Khalid, Sapna S Patel, Ira Kurtz, Ramy M Hanna, & Mina Hanna. (2019). Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy. Clinical Kidney Journal, 13(6).

Chicago

Lama Abdelnour, Michael Shye, Jean Hou, Collin Mccannel, Ngoc Tram-Tran, Maham Khalid, Sapna S Patel, Ira Kurtz, Ramy M Hanna, and Mina Hanna. 2019. “Worsening Proteinuria and Renal Function after Intravitreal Vascular Endothelial Growth Factor Blockade for Diabetic Proliferative Retinopathy.” Clinical Kidney Journal 13 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b427cb04a056be8d720add89a04c6589&authtype=sso&custid=ns315887.